Green Cross acquires the first tetravalent flu vaccine for multiple injections in Korea
On the 23rd, Green Cross(CEO Eun-cheol Huh) announced product approval of ‘GCFlu Quadrivalent Multi Inj,’ an tetravalent influenza vaccine, from the Ministry of Food and Drug Safety on the 20th.
The tetravalent influenza vaccine approved on Green Cross is a multi-injectable vial formulation whic...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
